GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q2 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $76,984,000 | +5.7% | 636,568 | -2.3% | 0.06% | +3.3% |
| Q4 2016 | $72,810,000 | -29.2% | 651,482 | -15.9% | 0.06% | -29.9% |
| Q3 2016 | $102,833,000 | +37.0% | 774,753 | -5.5% | 0.09% | +35.9% |
| Q2 2016 | $75,042,000 | -5.2% | 819,524 | -25.3% | 0.06% | -7.2% |
| Q1 2016 | $79,178,000 | +26.3% | 1,097,371 | +21.6% | 0.07% | +30.2% |
| Q4 2015 | $62,675,000 | -58.8% | 902,573 | -45.8% | 0.05% | -22.1% |
| Q3 2015 | $152,242,000 | +68.5% | 1,666,230 | +126.6% | 0.07% | -8.1% |
| Q2 2015 | $90,340,000 | +78.7% | 735,431 | +32.6% | 0.07% | +76.2% |
| Q1 2015 | $50,554,000 | +81.2% | 554,749 | +34.6% | 0.04% | +75.0% |
| Q4 2014 | $27,903,000 | -4.9% | 412,276 | +13.5% | 0.02% | -11.1% |
| Q3 2014 | $29,355,000 | -20.7% | 363,082 | +5.3% | 0.03% | -20.6% |
| Q2 2014 | $37,008,000 | +134.6% | 344,932 | +29.8% | 0.03% | +126.7% |
| Q1 2014 | $15,777,000 | – | 265,745 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |